Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum protein binding of valproic acid and its displacement by palmitic acid in vitro.

Literature DB >> 385026

Serum protein binding of valproic acid and its displacement by palmitic acid in vitro.

A Monks, A Richens.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1979 PMID： 385026 PMCID： PMC1429773 DOI： 10.1111/j.1365-2125.1979.tb05820.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

9 in total

1. PLASMA FREE FATTY ACIDS IN EXERCISE.

Authors: K RODAHL; H I MILLER; B ISSEKUTZ
Journal: J Appl Physiol Date: 1964-05 Impact factor: 3.531

2. Pharmacokinetics and bioavailability of sodium valproate.

Authors: U Klotz; K H Antonin
Journal: Clin Pharmacol Ther Date: 1977-06 Impact factor: 6.875

3. Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution.

Authors: P K Lunde; A Rane; S J Yaffe; L Lund; F Sjöqvist
Journal: Clin Pharmacol Ther Date: 1970 Nov-Dec Impact factor: 6.875

4. Effect of free fatty acids on binding of drugs by bovine serum albumin, by human serum albumin and by rabbit serum.

Authors: D Rudman; T J Bixler; A E Del Rio
Journal: J Pharmacol Exp Ther Date: 1971-02 Impact factor: 4.030

5. Influence of free fatty acid concentration on drug binding to plasma albumin.

Authors: A A Spector; E C Santos; J D Ashbrook; J E Fletcher
Journal: Ann N Y Acad Sci Date: 1973-11-26 Impact factor: 5.691

6. High-frequency oscillation of blood free fatty acid levels in man.

Authors: J M Court; M E Dunlop; R F Leonard
Journal: J Appl Physiol Date: 1971-09 Impact factor: 3.531

7. Circular dichroism studies on the inhibiting effect of oleic acid on the binding of diazepam to human serum albumin.

Authors: T Sjödin
Journal: Biochem Pharmacol Date: 1977-11-15 Impact factor: 5.858

8. Drug interactions. III. Binding to and displacement from bovine serum albumin of barbiturates.

Authors: S Ozeki; K Tejima
Journal: Chem Pharm Bull (Tokyo) Date: 1977-08 Impact factor: 1.645

9. Plasma protein binding interaction between phenytoin and valproic acid in vitro.

Authors: A Monks; S Boobis; J Wadsworth; A Richens
Journal: Br J Clin Pharmacol Date: 1978-12 Impact factor: 4.335

9 in total

10 in total

10. The effects of peritoneal dialysis on the single dose and steady state pharmacokinetics of valproic acid in a uremic epileptic child.

Authors: J M Orr; K Farrell; F S Abbott; S Ferguson; W J Godolphin
Journal: Eur J Clin Pharmacol Date: 1983 Impact factor: 2.953

10 in total

Serum protein binding of valproic acid and its displacement by palmitic acid in vitro.

1. PLASMA FREE FATTY ACIDS IN EXERCISE.

2. Pharmacokinetics and bioavailability of sodium valproate.

3. Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution.

4. Effect of free fatty acids on binding of drugs by bovine serum albumin, by human serum albumin and by rabbit serum.

5. Influence of free fatty acid concentration on drug binding to plasma albumin.

6. High-frequency oscillation of blood free fatty acid levels in man.

7. Circular dichroism studies on the inhibiting effect of oleic acid on the binding of diazepam to human serum albumin.

8. Drug interactions. III. Binding to and displacement from bovine serum albumin of barbiturates.

9. Plasma protein binding interaction between phenytoin and valproic acid in vitro.

Review 1. Influence of exercise on the pharmacokinetics of drugs.

2. Nonlinear binding of valproic acid (VPA) and E-delta 2-valproic acid to rat plasma proteins.

3. Serum protein binding of diazepam and its displacement by valproic acid in vitro.

Review 4. Pharmacokinetic interactions with antiepileptic drugs.

5. Differential transplacental binding of valproic acid: influence of free fatty acids.

6. Diurnal variations in steady-state plasma concentrations of valproic acid in epileptic patients.

7. The influence of free fatty acids on valproic acid plasma protein binding during fasting in normal humans.

Review 8. Drug interactions with valproic acid.

9. Pharmacokinetics of diazepam in epileptic patients and normal volunteers following intravenous administration.

10. The effects of peritoneal dialysis on the single dose and steady state pharmacokinetics of valproic acid in a uremic epileptic child.